On Nov. 26, 1997, the U.S. Food and Drug Administration (FDA) announced it had approved the Monoclonal antibody…
On Oct. 9, 1997, Stanford researchers announced that in a series of experiments performed in mice and rats,…
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
In 1997, the the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained NCI designated…
In 1998, Alfred Mann gave $112.5 million to establish the University of Southern California Alfred E. Mann Institute…
In 1997, Paul D. Boyer of the University of California at Los Angeles was awarded the Nobel Prize…
In 1997, the National Fibromyalgia Association (NFA), the largest nonprofit [501(c)3] organization working to support people with fibromyalgia…
On Jan. 2, 1996, Stanford Medicine researchers announced they had discovered that the p53 protein, known to be…
In 1996, Livermore National Lab delivered to the U.S. Army for testing the first fully portable, battery-powered, real-time…
In 1996, the Burnham Institute was named to honor the generosity of Roberta and Malin Burnham and their…
In 1996, Stanford Medicine researcher Developmental biologist Matthew Scott and a team at University of Califronia, San Francisco…
On Dec. 11, 1996, scientists from Stanford University and Affymetrix announced a new high-tech method that used a…
In 1996, the National Cervical Cancer Coalition (NCCC), a growing coalition of people battling cervical cancer and HPV…
On Dec. 29, 1995, the Genentech drug Nutropin AQ ((somatropin) injection for subcutaneous use) was approved by the…
On May 3, 1995, the U.S. Food & Drug Administration (FDA) announced it had approved Genentech’s drug CellCept…
In 1995, the first department of bioengineering in the U.S. was established at the University of California, San…
In 1995, Southern California Biomedical Council (SCBC), was founded with support from Rebuild LA (RLA) under its second…
On Oct. 26, 1994, the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained designated…
On May 17, 1994, the U.S. Food and Drug Administration (FDA) approved of the first genetically modified food:…
In 1994, Stanford Medicine researcher David Stevenson developed the new diagnostic instrument for rapid bedside screening of hemolysis…
In 1994, Amgen announced it had acquired Boulder-based Synergen for a $239.6-million or $9.25 per share. Synergen was…
In 1994, CyberKnife developed by John Adler, MD and colleagues at Stanford University. CyberKnife’s special quality is that…
On Dec. 30, 1993, the Genentech drug Pulmozyme (dornase alfa) was approved by the U.S. Food and Drug…
On Nov. 12 ,1993, FDA granted approval for the sale of the Ahmed Glaucoma Valve designed and manufactured…
In May 1993, the U.S. Centers for Disease Control and Prevention (CDC) responded to a Hantavirus outbreak in…
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
In 1993, Genentech drug Nutropin was approved by the U.S. Food and Drug Administration (FDA).
In 1993, Stanford Medicine researchers led by William Haskell demonstrated that lifestyle changes and drug therapy decrease heart…
In 1993, Kary B. Mullis of La Jolla, CA and a graduate of the University of California at…
In 1993, University of California, San Francisco (UCSF) researchers Cynthia Kenyon and colleagues’ announced they had discovered that…